L-Lysine a-oxidase (LysOX) from Trichoderma viride is a homodimeric 112 kDa flavoenzyme that catalyzes the oxidative deamination of L-lysine to form a-keto-eaminocaproate. LysOX severely inhibited growth of cancer cells but showed relatively low cytotoxicity for normal cells. We have determined the cDNA nucleotide sequence encoding LysOX from T. viride. The fulllength cDNA consists of 2,119 bp and encodes a possible signal peptide (Met1-Arg77) and the mature protein (Ala78-Ile617). The LysOX gene have been cloned and heterologously expressed in Streptomyces lividans TK24 with the enzyme activity up to 9.8 U/ml. The enzymatic properties of the purified recombinant LysOX, such as substrate specificity and thermal stability, are same as those of native LysOX. The crystal structure of LysOX at 1.9 Å resolution revealed that the overall structure is similar to that of snake venom L-amino acid oxidase (LAAO), and the residues involved in the interaction with the amino or carboxy group of the substrate are structurally conserved. However, the entrance and the inner surface structures of the funnel to the active site, as well as the residues involved in the substrate side-chain recognition, are distinct from LAAOs. These structural differences well explain the unique substrate specificity of LysOX.
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L-Lysine a-oxidase (LysOX) (EC 1.4.3.14) catalyzes the oxidative deamination of L-lysine to form a-keto-eaminocaproate along with the production of ammonia and hydrogen peroxide via an imino acid intermediate (1) . Most of known L-amino acid oxidases (LAAO) such as snake venom LAAO show wide substrate specificity, but oxidize L-lysine only slightly or not at all (2) . Unlike other LAAOs, LysOX from Trichoderma viride, which is found during the search for antitumor agents, exhibits high substrate specificity for L-lysine (Km = 40 mM) (1) . LysOX from T. viride is stable over wide range of pH and temperature. Trichoderma viride LysOX retains its enzyme activity even at 65 C. Thus the enzyme is a useful analytical tool for quantitative assay of L-lysine in food or in fermentation process, and an attractive candidate for an enzyme-based amino acid sensor (3) . In addition, LysOX from T. viride has strong antitumor activity against mouse leukaemic cells (1, 4) , and thus LysOX is expected to be a potential anti-cancer agent. A few other LysOXs are found in marine organisms such as the fish infected with Anisakis simplex and the rockfish Sebastes schlegeli (57). Among them, LysOX from T. viride is the sole commercially available one because LysOXs from other sources have not been well characterized. Trichoderma viride secretes LysOX in wheat bran medium, and long cultivation is required to obtain reasonable amount of LysOX. Therefore over expression of LysOX in other organisms that can grow in liquid medium is needed for further use of LysOX. LysOX from T. viride is a homo dimeric protein with an apparent molecular mass of 112 kDa (1), but molecular mechanisms of enzymatic reaction and substrate specificity are not well understood.
Here, we report the antitumor effect on human cancer cells, gene cloning and heterologous expression of LysOX from T. viride. We also show the crystal structure of LysOX from T. viride at 1.9 Å resolution and discuss the molecular mechanism of the substrate recognition of LAAOs. These progress and findings will provide a great contribution to further application of the enzyme.
Experimental Procedures
Bacterial strains, plasmids and culture conditions Trichoderma viride Y244-2 was used for purification of native enzyme and preparation of RNA. Cells were subcultured at 28 C for 3 days in a test tube containing 3 ml of liquid medium (5.0% D-glucose, 0.3% peptone, 0.25% meat extract, 0.05% MgSO 4 7H 2 O, 0.05% CaCl 2 2H 2 O). All subculture was inoculated into 3 l flask containing 120 g of wheat bran medium (120 g wheat bran supplemented with 84 ml of 5% glycine), followed by stationary cultivation at 28 C for 2 weeks. The culture was soaked in 900 ml of water at room temperature with gentle shaking and squeezed through a cloth. The aqueous extract was centrifuged to remove spores and mycelia for purification of native LysOX. Trichoderma viride Y244-2 cells used for total RNA preparation were grown aerobically at 28 C in a test tube containing 3 ml TGY medium (4% D-glucose, 1% peptone, 0.5% yeast extract, 0.5% KH 2 PO 4 and 0.2% MgSO 4 7H 2 O) for 3 days.
Escherichia coli TOP10 (Invitrogen) was grown aerobically at 37 C in LuriaBertani medium. Ampicillin (50 mg/ml) was added if the strain harbours a plasmid carrying an ampicillin-resistance gene.
An actinomycete strain, Streptomyces lividans TK24, was used as a host strain for heterologous expression. The Streptomyces transformants were subcultured at 28 C in a test tube containing 10 ml of YEME medium (0.5% peptone, 0.3% yeast extract, 0.3% malt extract (Oxid Ltd.), 1% D-glucose and 34% sucrose) supplemented with 20 g/ml thiostorepton. Then 1 ml of the subculture was inoculated into a 500 ml buffled flask containing 100 ml of YEME medium supplemented with 20 mg/ml thiostrepton, followed by incubation with 135 revolutions per minute (rpm) rotary shaking for 24 days.
Enzyme assay
The enzyme activity of LysOX was measured by detecting hydrogen peroxide using colour development method with 4-aminoantipyrine, phenol and horseradish peroxidase. One unit of enzyme activity was defined as the amount of enzyme catalyzing the formation of 1 mmol of hydrogen peroxide per minute. The assay mixtures contained 100 mM potassium phosphate buffer (KPB) at pH 7.4, 10 mM L-lysine, 300 U/ml horseradish peroxidase, 15 mM 4-aminoantipyrine, 50 mM phenol and an appropriate amount of enzyme. Reaction was carried out at 30 C for 5 min and monitored the absorbance at 505 nm by spectrophotometer. Protein concentration was determined by Bio-Rad Protein assay kit (Bio-Rad) using BSA as a standard.
Purification of Native LysOX from T. viride Y244-2 Native LysOX was purified to homogeneity as described previously (1) . The specific activity of the purified enzyme was 66.2 U/mg.
Purification of recombinant LysOX from S. lividans transformants All purification procedures were performed at 04 C. KPB at pH7.4 was used throughout the purification, unless noted otherwise. The 500 ml of cell culture was centrifuged for 15 min at 10,000 Â g at 4 C. Ammonium sulphate was added into the supernatant to 65% saturation, and the solution was stored at 4 C for 30 min. After centrifugation for 30 min at 10,000 Â g at 4 C, the precipitate was dissolved and dialysed against 20 mM KPB. The dialyzed solution was applied to a DEAEToyopearl 650 M column (Tosoh) equilibrated with 20 mM KPB. Protein was eluted with a linear gradient of NaCl from 0 to 0.5 M in 20 mM KPB. The active fractions were collected and then ammonium sulphate was added to 65% saturation. After centrifugation of the solution, the precipitate was dissolved in 20 mM KPB, followed by dialysis against 20 mM KPB. The protein solution was brought to 20% ammonium sulphate saturation, and placed on a Butyl-Toyopearl 650 M column (Tosoh) equilibrated with 20 mM KPB containing 20% saturated ammonium sulphate. The protein was eluted with a linear gradient of ammonium sulphate (from 20 to 0% saturation) in 20 mM KPB. The active fractions were combined and the protein was precipitated with ammonium sulphate at 65% saturation. The precipitate was collected by centrifugation, dissolved in 20 mM KPB, and then dialyzed. The purity of the protein was examined by sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDSPAGE).
Cytotoxicity assay RERF-LC-AI, HeLa and human umbilical vein endothelial cells (HUVECs) (1Â 10 4 cells/well) were seeded in 96-well plates and cultured at 37 C under 5% CO 2 and 20% O 2 in a humidified chamber for 24 h. Then 5 ml of LysOX (1 or 3 mU/ml) was added to the cells and further incubated for 4 days. The cell viability (proliferation) was examined using the thiazolyl blue tetrazolium bromide (MTT) assay according to the manufacturer's instructions (Sigma-Aldrich, St. Louis, MO). Absorbance of the converted dye colour was measured at 570 nm. Cell viability was expressed as the percentage of absorbance in the treated cells to that in the control cells. Each assay was repeated at least three times. The cells were examined and photographed by an inverted phase-contrast microscope (Olympus, IX71).
Effect of temperature on enzyme activity and stability The optimal temperature of the recombinant enzyme was determine by measuring the enzyme activity at 2080 C in 100 mM KPB (pH 7.4). To determine the thermostability, each enzyme solution (1.6 mg/ ml) was preincubated for 30 min at corresponding temperature, and later the residual activity was measured by the standard assay method at 30 C.
cDNA cloning of the LysOX gene
To determine the N-terminal sequence and internal sequence of LysOX, a protein band of 56 kDa was resolved by SDSPAGE, excised from the gel and digested in-gel with lysyl endopeptidase. The peptides were isolated by reverse phase HPLC and analyzed by amino acid sequencer. Two primers, primer1 (CGTAGGCGCT GGTGTTTCC) and primer2 (CCCGTGC TTCCCCGTCTCTA), were synthesized on the basis of the nucleotide sequence of lao of Trichoderma harzianum, which shows high homology with internal sequence of LysOX, and were used for RT-polymerase chain reaction (PCR). Total RNA was extracted from T. viride with TRIzol reagent (Invitrogen). The first-strand and the second-strand cDNA were synthesized with cDNA Synthesis System kit (GIBCO BRL).
RT-PCR conditions used were 94 C for 2 min; 30 cycles of 94 C for 1 min, 63 C for 1 min and 72 C for 1.5 min and 72 C for 20 min. A 1.5 kb PCR product was obtained, and subsequently sequenced after subcloning into the pCR2.1-Topo vector. 5 0 -RACE was carried out according to the procedure of the 5 0 -RACE System for SMART RACE cDNA Amplification Kit (Clontech) following the manufacturer's instructions. Oligonucleotide primers were included in the kit. 
Construction of expression plasmids
The sequence encoding the enzyme was amplified by PCR with pUC19-lysox as a template. The following two primers were used; forward primer F1 (5 0 -GATGAAAG GAATGAGCATatggacaatgttgactttgctgaatctgtccgaac-3 0 ) containing an NdeI recognition site (underlined), and reverse primer R1 (5 0 -CCGCTTTTGCGGG GATCTAGA ttagatcttcacctggtactccttgggaagcg-3 0 ) containing an XbaI recognition site (underlined). The DNA fragment between NdeI and XbaI of the PCR product was introduced into NdeI/ XbaI-digested pHSA81 to construct pHSA81-lysox, and the resultant plasmid was transformed into S. lividans TK24. To overproduce LysOX in Streptomyces host cells, a synthetic lysox2 gene optimized codon usage for S. lividans was used. The lysox2 gene was commercially synthesized by GenScript Inc. (Tokyo) as the third base of the codon was G or C. The forward primer F2 (5 0 -GATGAAAGGAAT GAGCATatggacaacgtggacttcgccgagtc-3 0 ) containing an NdeI recognition site (underlined), and reverse primer R2 (5 0 -CCGCTTTT GCGGGGATCTAGA ttagatcttcacctggtactccttggggag-3 0 ) containing an XbaI recognition site (underlined) were used for pHSA81-lysox2 construction. The nucleotides of the resultant plasmids were sequenced and checked. In the both constructs, each lysox gene was under the control of the H-NHase promoter.
Crystallization
The crystallization was performed by using the purified native LysOX derived from T. viride. Initial crystallization screening was carried out at 273 K and 293 K by the sitting-drop vapor-diffusion technique using the following screening kit: Wizard I and II, Cryo I and II (Emerald Biostructures) and Crystal Screen I and II (Hampton Research). Each drop was prepared by mixing 0.5 ml protein solution (4.9 mg/ml) containing 20 mM HEPES (pH 7.4) with 0.5 ml reservoir solution and equilibrated against 70 ml reservoir solution. Within a week, small rod crystals were grown in drops containing high concentration of ammonium sulphate or potassium/ ammonium phosphate under neutral to alkaline condition. These crystals were diffracted up to 2.7 Å resolution using a synchrotron beamline, but they tend to grow into clusters of small rod crystals. Then we optimized the conditions by varying the precipitant concentration, pH and additives using the hanging-drop method. The crystals suitable for X-ray analysis at high resolution were obtained from drops prepared by mixing 1 ml protein solution (4.6 mg ml À1 ) with 1 ml reservoir solution containing 0.1 M HEPES-NaOH (pH 7.6), 2% (v/v) PEG-400 and 1.8 M ammonium sulphate at 293 K. The crystals appeared within a few days and grew to typical dimensions of 0.05 Â 0.01 Â 0.3 mm.
Data collection and processing
The X-ray data were corrected at SPring-8 beamlines, BL38B1 and BL41XU, (Harima, Japan) with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2010A1814 and 2012A1441). Crystals were soaked in a cryo-protectant solution containing 10% (v/v) glycerol and 90% (v/v) of the reservoir solution for several seconds, and were transferred into liquid nitrogen for freezing. The diffraction data were collected on a MX225HE CCD detector (Rayonix) under nitrogen gas flow at 95 K. The diffraction data were indexed and integrated with MOSFLM (8) , and were scaled with SCALA (9) . The diffraction data statistics are summarized in Table I . The initial phase was obtained by molecular replacement method with PHENIX (10) using the structure of LAAO from Vipera ammodytes (PDB: 3KVE) as a search model. The atomic model was built with Coot (11) and refined to 1.9 Å with PHENIX (10). Tow LysOX molecules were present in the asymmetric unit. After many rounds of refinement including manual modification of the model, the refinement R factor (R work ) and the free R factor (R free ) were converged to 15.9% and 18.8%, respectively. The Ramachandran plot indicated that 93.3% and 6.4% residues were located in the most favourable and allowed region, respectively. Two residues (Arg-348 in both molecules) were in disallowed region. The structural refinement statistics are shown in Table I .
Size exclusion chromatography Analytical size exclusion chromatography was conducted with a Superdex 200 HR 5/150 column (GE Healthcare) connected to an AKTA chromatography system (GE Healthcare). The column was equilibrated with phosphate buffered saline (PBS) buffer (10 mM potassium phosphate (pH 7.3), 137 mM NaCl), and the 50 ml of sample protein solution (1 mg/ml) was eluted with a flow rate of 0.4 ml/min.
Results and Discussion
Antitumor effect and cytotoxicity Previous studies reported that LysOX from T. viride has strong cytotoxicity to mouse cancer cells (1, 4) . Here, we examined the cytotoxicity effect of LysOX on human cancer cells RERF-LC-AI (human lung squamous cell carcinoma cell line) and HeLa (human cervical cancer cell line), and normal control cells HUVECs by MTT assay. Cell proliferation was assessed at 4 days after treatment with 1 or 3 mU/ml of LysOX. Cell proliferation was expressed as a percentage of proliferation compared with the proliferation in PBS without LysOX. The proliferations of RERF-LC-AI and HeLa cells with 3 mU/ml of LysOX were significantly less than that of the control (Fig. 1A and B) . In contrast, the cell proliferation of HUVEC cells was more than 80% even in the presence of 3 mU/ml of LysOX, indicating that the cancer cells are more sensitive to LysOX than normal cells. The cytotoxic (cell-killing) effect of LysOX is probably caused by H 2 O 2 produced by enzymatic reaction. The higher sensitivity of cancer cells might be associated with the deficiency of antioxidative enzymes, such as catalase and glutathione peroxidase and superoxide dismutase (12) . The exhaustion of L-lysine in the medium also affects the higher sensitivity of cancer cells. Since L-lysine is an essential amino acid for human cells (13) , and cancer cells require a much larger amount of L-lysine than normal cells. Thus LysOX is a potential useful tool for cancer therapy.
Cloning and sequencing of the lysox gene To clone the LysOX gene from T. viride, we determined the N-terminal and three internal amino acid sequences of LysOX by amino acid sequencer. The N-terminal peptide sequence was AEEELPPRKV XIVGAGVSGLY and the internal sequences were LQQAFGY, YYLDGENTTQ and GFDELML VDDMT. A BLAST search with these sequences revealed that LysOX shows a significant sequence Values in parentheses are for the highest resolution shell. R w = AE jj Fo j À j Fc jj / AE j Fo j, R free = AE jj Fo j À j Fc jj / AE j Fo j. (mU/ml) (mU/ml) (mU/ml) MLVDDMT are found at positions 643663, 505534 and 697732, respectively (Fig. 2) . These results suggest that LysOX is synthesized as a precursor and the N-terminal 77 residues are cleaved to produce the mature protein composed of 541 amino acid residues. FASTA database searches revealed that LysOX from T. viride Y244-2 shows sequence similarity to LAAOs derived from fish infected with Anisakis simplex (24%) (5), Se. schlegeli (24%) (14) and Calloselasma rhodostoma (18%) (15) . The LAAOs from fish infected with A. simplex and Se. schlegeli have high substrate specificity for L-lysine, like LysOX from T. viride (5, 7).
Expression of LysOX in Streptomyces lividans TK24
In order to overproduce LysOX in Streptomyces, we used a hyper-inducible expression plasmid pHSA81 as a vector (16) , and constructed two types of expression vectors, pHSA81-lysox and pHSA81-lysox2, carrying Recombinant expression and crystal structure of L-lysine a-oxidase the native lysox gene and a synthetic lysox gene optimized for codon usage in Streptomyces, respectively. Each expression vector was transformed into S. lividans TK24 cells. Each transformant was inoculated and cultivated for 24 days, and enzyme activity of the culture supernatant was measured every 3 days (Fig. 3) . Streptomyces lividans TK24 cells harbouring pHSA81-lysox2 showed more than six times higher enzyme activity than those harbouring pHSA81-lysox. Maximum enzyme activity (9.8 U/ml) was observed after 21 days cultivation. We analyzed the supernatant by SDSPAGE, and detected a 56 kDa protein band corresponding to LysOX (Fig. 4) , but only small amount of the enzyme was detected in the cell. These findings suggest that LysOX from T. viride is secreted in the culture medium, even when Streptomyces is used as a host cell.
Purification and property of recombinant LysOX
Recombinant LysOX secreted in culture supernatant was purified to homogeneity through ammonium sulphate fractionation and two-step column chromatography. The purification scheme was based on that for native LysOX, but the heat treatment and the third chromatographic step were eliminated (Table II) . The specific activity of the purified recombinant enzyme was 80 U/mg, which is comparable to that of the native enzyme (66 U/mg) (1). There was no detectable difference in apparent molecular mass between the recombinant LysOX and the native one on SDSPAGE (Fig. 4) . The N-terminal amino acid sequence of the purified recombinant LysOX, however, is EELPPRKV, which is one residue shorter than that of the native enzyme (AEEELPPRKV). We investigated the substrate specificity of recombinant LysOX using various amino acids at 1 mM in the standard reaction mixture. Among the amino acids tested, L-lysine was the best substrate for the enzyme. The enzyme showed activity toward L-ornithine(18.3%), L-arginine(6.9%), L-phenylalanine(1.7%) and L-tyrosine(1.4%) compared with L-lysine. We examined the effect of temperature on the activity and stability. The optimal temperature of the recombinant LysOX was 50 C and stbale below 60 C. These data are consistent with a previous report (1) and indicate that the recombinant LysOX produced in S. lividans TK24 is enzymologically identical to the native T. viride LysOX.
Overall structure of LysOX
The crystal structure of LysOX was determined at 1.9 Å resolution with an R work of 15.8% and an R free of 18.9% (Fig. 5) (Table I ). The LysOX crystal belongs to the space group P2 1 2 1 2 and the crystallographic asymmetric unit includes two LysOX molecules (Fig. 5B) , which are basically identical in structure (The root mean-square deviation between the two molecules was 0.43 Å ). The N-terminal three residues and the C-terminal 28 residues of both molecules were invisible in the electron density map, therefore not modelled. Each LysOX molecule binds an FAD and two HEPES, one is located near the putative active site and the other is near the N-terminus. The final model contains two LysOX (Glu4-Leu512), two FAD, four HEPES and 786 bound solvent molecules. The overall structure of LysOX (Fig. 5A) resembles LAAOs from snake venom (15, 1721) , although the amino acid sequence identity to the snake LAAOs is only $20% (Fig. 6) . Like other well studied LAAO, such as LAAO from Calloselasma rhodostoma (Cr-LAAO) (17) and Lglutamate oxidase (LGOX) (22) , LysOX consists of three domains, the FAD-binding domain (Glu3-Gly7, Gly230-Leu312 and Phe442-Leu512), the substratebinding domain (Arg48-Ala109, Pro222-Gly229 and His313-Leu441) and the helical domain (Lys110-Lys221) (Fig. 5A) . The FAD-binding domain includes 8 a-helices and 9 b-strands, and the substrate-binding domain contains 4 a-helices and 14 b-strands. The two domains are structurally similar to those of Cr-LAAO except for the N-and the C-terminal regions, the turn between S13 and S14, and the loop connecting H13 and H14 (Val382-Asp393). FAD is located in the interface of these domains, and the FAD conformation and its binding manner resemble those seen in other LAAOs. Although half of the residues involved in the FAD interaction are not conserved, the main chain atoms of these residues can be superimposed with root-mean-square deviations of 0.70 Å . This probably reflects that the protein interacts with FAD mainly through the main chain atoms. The helical domain consists of 7 a-helices. The structure of this domain, especially the region from Lys110 to Leu160, shows significant difference from other LAAOs (Fig. 6 ).
Tertiary structure of LysOX
Each molecule in the asymmetric unit forms a dimer with its neighbouring molecule related by crystallographic 2-fold axis (Fig. 5B and C) . The two dimers form a tetramer through the interaction between the substrate-binding domains (Fig. 5C ). The regions connecting S3 and S4, S16 and S17, S18 and S19, H13 and H14 and H15 and S21 contribute to the dimer-dimer interaction. The subunit arrangement of the tetramer is essentially identical to LAAO of Vipera ammodytes ammodytes (Vaa-LAAO). The Vaa-LAAO tetramer is stabilized by zinc ions bound to the subunit interface (21) , but LysOX has no bound divalent cation in its tetrameric structure. We observed no tetramer but only dimer in PBS in size exclusion chromatography, suggesting that the active form of LysOX is dimer. The LysOX tetramer may be a packing artefact or may have some unknown role only under a certain condition.
The funnel structure
The long funnel to the active site is a common feature of many flavoenzymes including the LAAOs (22) . The funnel and its entrance are composed of the helical domain on one side and the substrate-binding domain on the other side. As described above, the helical domain of LysOX substantially differs from other LAAOs, and thus shape of the funnel entrance is distinct from other LAAOs. This structural difference suggests that the funnel entrance is one of the determinants of the substrate specificity of LAAOs.
Mapping of the electrostatic potential on the molecular surface of LysOX indicates that the entrance and the inside of the funnel are acidic compared with other LAAOs (Fig. 7) . In fact, the number of the acidic residues and the basic residues on the funnel surface of LysOX are 10 and 5, respectively; while those of Cr-LAAO are 7 and 8, and those of LGOX are 6 and 8. This surface property probably also contributes to the strict substrate specificity of LysOX.
Pawelek et al. (17) proposed the substrate trajectory of LAAO on the basis of the Cr-LAAO structure in complex with o-amino benzoate. On the trajectory, the carboxy group of o-amino benzoate keeps facing to the positively charged funnel wall made up of the substrate-binding domain. In LysOX, the funnel surface composed of the helical domain is highly acidic, but the substrate-binding domain is neutral to weakly basic (Fig. 7) . Thus L-Lysine may trace the similar trajectory to the active site in the LysOX funnel.
Structure of the putative active site
The structural similarity to LAAO allowed us to assign the putative substrate-binding site of LysOX. The residues responsible for the interaction with the amino or carboxy group of the substrate phenylalanine in Cr-LAAO (19) are structurally well conserved in LysOX (Fig. 8) . Arg68, Tyr369 and Trp476 are located in identical positions to their corresponding conserved residues of Cr-LAAO. The carboxy group of the substrate L-phenylalanine interacts with the side chains of Arg68 and Tyr369, and the amino group of the substrate interacts with the main-chain carbonyl oxygen of Gly464 in Cr-LAAO. Although Gly464 is replaced by Ala475 in LysOX, the main-chain atoms of Ala475 are present at almost the same positions of those of Gly464. These structural similarities suggest that LysOX binds L-lysine with similar orientation as L-phenylalanine in Cr-LAAO. In contrast to the recognition of the amino-acid backbone, the residues involved in the interaction with the substrate side-chain atoms are not conserved. His223, Ile374, Ile430 and Arg322, which surround the substrate phenyl ring in Cr-LAAO (19) , are substituted by Asp212, Trp371, Phe439 and Asp315, respectively, in LysOX. Substitution to bulky Trp371 and Phe439 significantly reduce the active site space with a contribution of the side chain methyl group of Ala475, which points to inward of the substrate-binding pocket. Two acidic residues, Asp212 and Asp315, protrude into the Recombinant expression and crystal structure of L-lysine a-oxidase substrate-binding pocket, thus either or both residues are thought to recognize the e-amino group of lysine. The corresponding acidic residues are not present in the active site of the snake LAAOs, but the corresponding residues of Asp315 is conserved in LGOX (Fig. 6A) , implying Asp212 interacts with the e-amino group.
Implication for substrate recognition mechanism of LysOX The putative active site structure of LysOX provides a clue to understand the strict substrate recognition of LysOX. Amino acids with bulky side-chain cannot be accommodated in the relatively narrow binding-site of LysOX. The amino acids with small side chain may not be able to be well fixed in the active site because of less interaction between the small side-chain and the enzyme, resulted in less activity. The strong acidic environment produced by Asp212 probably repels acidic and hydrophobic amino acids from the substrate-binding pocket. LysOX shows low activity for arginine (1) . The side chain of arginine can be recognized by Asp212 or Asp315 through the positive charge of the guanidino group. However, the side chain is slightly longer than lysine, and probably the amino acid backbone atoms of arginine may not be placed in proper position for deamination. On the basis of the structure of LysOX, we propose a possible mechanism for the substrate recognition of LysOX. The first selection of the substrate may be conducted at the entrance of the funnel. The acidic property of the funnel entrance attracts the positively charged substrate (Fig. 7) , but the selection may not be strict because a HEPES molecule is found in the funnel in the crystal structure of LysOX. The second selection is made on the way to the substrate-binding site. The slightly positively charged lane of the funnel surface constructed by the substrate-binding domain leads the substrate to the active site with proper orientation (Fig. 7) . Other funnel surface is negatively charged, and thus highly negatively charged molecules cannot go into the funnel bottom. The substrate reached to the active site is then recognized by Arg68, Tyr369, Trp476 and carbonyl oxygen of Ala475, which are conserved in various LAAOs. The e-amino group of lysine is bound to Asp212 (and/or Asp315), and the substrate is firmly fixed with suitable orientation for reaction (Fig. 8) . To fully understand the substrate recognition mechanism of LysOX, the substrate complex structure and mutational analyses are required, and such studies are now in progress. 
